MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Waters Corporation Cost of Revenue 2011-2026 | WAT
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Waters Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 349 M | 318 M | 568 M | 351 M | 1.01 B | 1.01 B | 993 M | 947 M | 891 M | 843 M | 825 M | 783 M | 738 M | 730 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 B | 318 M | 740 M |
Quarterly Cost of Revenue Waters Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 M | 164 M | 152 M | - | - | - | - | - | - | - | - | - | - | - | - | 351 M | 271 M | 280 M | 254 M | 321 M | 262 M | 213 M | 211 M | 299 M | 241 M | 250 M | 221 M | 287 M | 241 M | 243 M | 221 M | 270 M | 236 M | 230 M | 211 M | 252 M | 218 M | 220 M | 201 M | 238 M | 207 M | 209 M | 189 M | 233 M | 202 M | 202 M | 188 M | 229 M | 192 M | 188 M | 175 M | 208 M | 183 M | 179 M | 167 M | 204 M | 180 M | 176 M | 170 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 351 M | 152 M | 221 M |
Cost of Revenue of other stocks in the Diagnostics research industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
162 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
608 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
3.86 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
28.4 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
6.6 M | $ 23.56 | -2.04 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
144 M | $ 33.99 | 0.65 % | $ 366 M |  China |
 |
Accelerate Diagnostics
AXDX
|
9.45 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
30.4 M | $ 1.38 | -6.12 % | $ 1.75 M | USA |
 |
Castle Biosciences
CSTL
|
60.2 M | $ 39.01 | -0.38 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
38.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
4.18 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
9.67 B | $ 218.94 | -0.24 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
221 M | $ 102.48 | 0.18 % | $ 19 B | USA |
 |
DermTech
DMTK
|
15 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
183 M | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
176 M | $ 26.01 | -0.88 % | $ 786 M | USA |
 |
Genetic Technologies Limited
GENE
|
276 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
194 M | - | 0.12 % | $ 80.1 M | China |
 |
DexCom
DXCM
|
1.33 B | $ 73.26 | -1.0 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
45.5 M | $ 20.4 | -1.92 % | $ 1.1 B | USA |
 |
DarioHealth Corp.
DRIO
|
14.4 M | $ 10.95 | 6.31 % | $ 311 M | Israel |
 |
Enzo Biochem
ENZ
|
17.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
546 M | $ 65.82 | -1.3 % | $ 4.55 B | USA |
 |
Heska Corporation
HSKA
|
146 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.57 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.51 B | $ 145.95 | -2.5 % | $ 23.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
801 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
10 B | $ 230.03 | -2.31 % | $ 41.7 B | USA |
 |
NeoGenomics
NEO
|
370 M | $ 11.85 | -4.44 % | $ 1.5 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.63 B | $ 184.82 | 1.37 % | $ 20.5 B | USA |
 |
Personalis
PSNL
|
57.8 M | $ 9.4 | -5.72 % | $ 557 M | USA |
 |
Motus GI Holdings
MOTS
|
81 K | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
9.18 M | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.38 B | $ 269.39 | -0.16 % | $ 22.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
3.97 B | $ 179.07 | -3.67 % | $ 14.8 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.52 B | $ 674.78 | -0.29 % | $ 55.6 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.99 B | $ 28.73 | -1.79 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
2.91 B | $ 132.75 | -0.37 % | $ 40.4 B | USA |
 |
Biomerica
BMRA
|
4.81 M | $ 2.39 | 0.21 % | $ 5.49 M | USA |